WEBINAR:
VR Meets Chemistry
Accelerating Synthesis Design & using Collaborative Mixed Reality
SYNTHIA™ Retrosynthesis Software is a powerful tool that combines sophisticated algorithms, advanced chemical logic and a unique database of expert-coded chemistry rules to quickly find viable pathways for synthetic targets.
The ability to differentiate between ‘easy-to-make’ and ‘difficult-to-make’ molecules is a challenging, but necessary task, for prioritizing compounds in large virtual screening libraries. By combining the modern deep-learning model, and data collected with our renowned retrosynthetic planning software, we deliver SYNTHIA™ Synthetic Accessibility Score (SAS) service, a tool applicable to high-throughput in-silico compounds processing. In this webinar, learn more about SYNTHIA’s SAS service and how it can be easily integrated with your digital research ecosystem through our API.
Nanome® is a virtual reality platform for molecular design and structure-based drug discovery used by pharma and biotech companies to accelerate drug discovery and collaborate in real time with teams around the globe. In this webinar, we are going to explore how Nanome®’s collaborative virtual environment can leverage the retrosynthesis workflows supported by SYNTHIA™ Retrosynthesis Software.
Key Learning Objectives:
- Learn how SYNTHIA combines sophisticated algorithms with advanced chemical knowledge to automatically plan full step-by-step pathways to know and novel molecules.
- Learn how SYNTHIA can help you reduce risk in the lab by providing decision making support for route planning
- Learn how SYNTHIA’s Synthetic Accessibility score can help you prioritize virtual compounds based on ease of synthesis
- Discover how virtual reality can be integrated into the process of pathway design for chemists leveraging SYNTHIA
- Getting up to speed with VR, one of the most promising analysis and visualization technologies for drug discovery
Speaker
Emma Gardener, Ph. D.
Technical Application Scientist
Emma Gardener received her undergraduate degree from Trinity College and worked for several years as a research associate in the biotechnology industry before completing her Ph.D. in Organic Chemistry at Brown University as an NSF graduate research fellow. She studied under Prof. Jason Sello, where she worked on developing new methodology for the synthesis of antibacterial peptide natural products. In 2018, she joined the Cheminformatics Technologies department of MilliporeSigma as a Technical Application Scientist and is responsible for the commercial licensing of the retrosynthetic design software, SYNTHIA™.
Maciej Wójcikowski, Ph.D.
Cheminformatics Lead, Digital Center of Excellence
Maciej Wójcikowski holds PhD in Biophysics from Institute of Biochemistry and Biophysics Polish Academy of Sciences in Warsaw. His area of research was in-silico drug discovery methods, with Machine Learning based approaches being a major part of his thesis. Maciej joined Synthia R&D group in 2018 and was working on improvements to Synthia cheminformatics predictions ever since. Now serves as a Cheminformatics Lead as part of Digital Center of Excellence.
Edgardo Leija
Co-founder & Chief Experience Officer, Nanome
Edgardo Leija is a Co-founder and the Chief Experience Officer at Nanome, a software development company that serves the scientific research community. After pursuing studies in computer science, neuroscience, and cognitive science, he obtained his degrees from the University of California, San Diego. Edgardo previously worked at Google and Hewlett-Packard, where he focused on human-centered product design and implementing systems to improve the overall customer experience. At Nanome, he works on expanding Nanome's reach in the pharmaceutical and biotech industries to help them leverage the best computational chemistry tools through an immersive virtual environment that facilitates effective collaboration amongst scientists.